Keyphrases
Lynch Syndrome
100%
Confidence Interval
62%
Inflammatory Bowel Disease
60%
Odds Ratio
53%
Meta-analysis
47%
Colorectal Cancer
46%
Mismatch Repair
40%
Systematic Meta-analysis
39%
Colonoscopy
35%
Transforming Growth Factor-β
32%
Crohn's Disease
32%
MSH6
30%
MSH2
29%
Israeli
27%
Liver Transplantation
27%
Population-based Study
27%
Israel
25%
Biological Warfare
24%
Hazard Ratio
24%
Israeli Adolescents
24%
Risk Factors
24%
Pathogenic Variants
24%
Cancer Risk
20%
Pancreatic Cancer
19%
High Risk
19%
Ashkenazi Jews
19%
Body Mass Index
18%
Young Patients
18%
Ulcerative Colitis
18%
Surveillance Colonoscopy
18%
Growth Factor Signaling
18%
Risk Reduction
17%
Infliximab
17%
Colon Cancer
17%
MLH1
17%
Celiac Disease
17%
Mismatch Repair Genes
16%
Neoplasia
16%
Hepatitis B Immunoglobulin
16%
Adenoma
15%
Colonoscopy Surveillance
15%
Endometrial Cancer
15%
Salpingo-oophorectomy
14%
Cancer Stage
14%
Diagnostic Performance
14%
Hysterectomy
14%
Ashkenazi
13%
Hepatocellular Carcinoma
13%
PMS2
13%
BRCA1, BRCA2
12%
Medicine and Dentistry
Hereditary Nonpolyposis Colorectal Cancer
89%
Colorectal Carcinoma
58%
Odds Ratio
55%
Colonoscopy
51%
DNA Mismatch Repair
50%
Inflammatory Bowel Disease
47%
Meta-Analysis
41%
Diseases
39%
Malignant Neoplasm
36%
Neoplasm
35%
Systematic Review
33%
Cancer Risk
32%
Crohn's Disease
31%
Polyp
24%
Body Mass Index
22%
Hazard Ratio
22%
Ovarian Cancer
20%
Salpingooophorectomy
19%
Pancreas Adenocarcinoma
19%
Ulcerative Colitis
19%
Pancreas Cancer
18%
BRCA1
17%
Liver Transplantation
17%
Cancer
16%
Adenoma
16%
Cancer Growth Factor
16%
Intracranial Tumor
16%
Uterine Cancer
15%
Cancer Screening
14%
Hysterectomy
14%
Cohort Analysis
13%
Common Bile Duct Stone
13%
Alanine Aminotransferase
13%
Retrospective Study
13%
Patient with Inflammatory Bowel Disease
13%
Gene Repair
13%
Hepatocellular Carcinoma
13%
Recurrent Disease
12%
APC
12%
Abdominal Cancer
12%
Prevalence
12%
Germline Mutation
12%
Proton-Pump Inhibitor
12%
Coeliac Disease
11%
Comorbidity
11%
Virus
11%
Hepatitis B
11%
Polypectomy
11%
BRCA2
11%
Diverticulitis
10%